Cart
0

Prosthetic Heart Valve Market by Product (Mechanical Heart Valve, Tissue Heart Valve (Stented Tissue Heart Valve, and Stentless Tissue Heart Valve), and Transcatheter Heart Valve) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Get 20% Free Customization In This Report
LI_172176
Pages: 250
May 2017 | 2537 Views
 
Author's : Amrita Srivastava & Deepa
Tables: 60
Charts: 156
 

Prosthetic Heart Valve Market Overview

Global Prosthetic Heart Valve Market was valued at $3,874 million in 2016, and is expected to reach at $8,392 million by 2023, growing at a CAGR of 11.4%. Prosthetic heart valve is a device implanted in a patient suffering from valvular heart disease, which results in malfunction of one or more valves (out of a total four valves) present in the human heart. The treatment for such disease includes replacement of a natural heart valve with a prosthetic heart valve.

Rise in prevalence of cardiac disorders, such as rheumatic heart diseases, increase in geriatric population, change in lifestyle of people, novel technological advancements in prosthetic heart valves, increase in patient awareness, demand for minimally invasive cardiovascular surgeries, and rise in number of transcatheter heart valve surgery centers drive the market growth. However, high cost and risk associated with prosthetic heart valves and stringent approval process (as formulated by FDA and other regulatory bodies) for prosthetic heart valves restrain the market growth. The growth opportunities in emerging countries of Asia-Pacific and LAMEA and use of transcatheter heart valves for new indications (treatment of intermediate-risk patients and high risk patients) are expected to provide numerous opportunities for the market growth during the forecast period.

Prosthetic Heart Valve Market Segmentation

Prosthetic Heart Valve Market Segmentation

Get more information on this report : Request Sample Pages

Segment Review

The transcatheter heart valve segment accounted for the highest market share in 2016, due to rise in prevalence of aortic stenosis and increase in geriatric population. In addition, rise in adoption rate for transcatheter heart valve implantation procedure and new device approvals are expected to lead the growth of transcatheter heart valve market. Moreover, use of transcatheter heart valves for new indications is a major opportunity for the market growth.

Snapshot of Lamea Prosthetic Heart Valve Market

Rise in incidence of structural heart diseases and rapid adoption of prosthetic valves drive the growth of the prosthetic valves market in LAMEA. There is an increase in prevalence of cardiac disorders, such as aortic stenosis in the Latin America due to lack of efficient treatment systems in these countries. In addition, the Latin American countries have reduced gross income leading to less expenditure on the development of new methods and devices, resulting in increase in need for efficient treatment systems. This increase in demand has attracted several key players from the West to invest in the Brazilian market for the growth of their transcatheter heart valve business. Israel offers an emerging market for transcatheter heart valve implantation procedure, owing to increase in geriatric population and rise in demand for unmet treatment procedures, which boost the market growth. Lack of facilities and an increased need for treatment devices have drawn the key players to invest in the Middle Eastern market.

Oman Prosthetic Heart Valve Market, 2016-2023 (Units)

Oman Prosthetic Heart Valve Market, 2016-2023 (Units)

Get more information on this report : Request Sample Pages

Clinical trials

The prosthetic valves market has witnessed several clinical trials in the recent years. Transcatheter valves accounted for the highest number of clinical trials in the market, owing to their high durability and lower requirement for anticoagulation therapy. The European countries conduct maximum number of clinical trials as a result of high prevalence of heart diseases, such as aortic stenosis and mitral regurgitation. For instance, in Europe, more than 1.75 million people suffer from aortic stenosis. In addition, mechanical valves trials were highest in Europe (about 45.6%) followed by North America (38.1%).

Clinical Trials for Prosthetic Heart Valves (%)

Clinical Trials for Prosthetic Heart Valves (%)

Get more information on this report : Request Sample Pages

The list of key players profiled in this report include Abbott Laboratories, Medtronic plc., Medical Technology Est., Boston Scientific Corporation, Micro Interventional Devices, Inc., Direct Flow medical, Inc., Edwards Lifesciences Corporation, LivaNova PLC., JenaValve Technology, Inc., and Cryolife, Inc.

Key players in the value chain include Corvia Medical, Inc., CardioKinetix, Inc., Biomerics, LLC., Lepu Medical Technology (Beijing) Co., Ltd., XELTIS BV, Comed B.V., HLT, Inc., Meril Life Sciences Pvt. Ltd., SYMETIS SA, and Transcatheter Technologies GmbH.

Key Benefits

  • The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets.
  • It offers a quantitative analysis and comprehensive analysis of all geographical regions from 2016 to 2023, to enable the stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis by product helps understand the various types of devices used for the treatment and monitoring of the cardiac patients.
  • Key players are profiled and their strategies are analyzed thoroughly, which helps understand the competitive outlook of the global market.

Prosthetic Heart Valve Market Key Segments

By Product

  • Mechanical Heart Valve
  • Tissue Heart Valve
  • Stented Tissue Heart Valve
  • Stentless Tissue Heart Valve
  • Transcatheter Heart Valve

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • The Netherlands
    • Turkey
    • Belgium
    • Switzerland
    • Russia
    • Denmark
    • Austria
    • Norway
    • Poland
    • Sweden
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • Malaysia
    • Republic of Korea
    • New Zealand
    • Singapore
    • Thailand
    • Vietnam
    • Taiwan
    • Indonesia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • United Arab Emirates (UAE)
    • Libya
    • Algeria
    • Kenya
    • Kuwait
    • Jordan
    • Sudan
    • Morocco
    • Israel
    • Zimbabwe
    • Mauritius
    • Oman
    • Argentina
    • Iran
    • Iraq
    • Rest of LAMEA
 

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY

2.1. KEY FINDINGS OF THE STUDY

2.2. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.2.2.1. Competitive intelligence of companies and their strategies

3.2.3. Market share analysis, 2016

3.3. MARKET DYNAMICS

3.3.1. Drivers

3.3.1.1. Rise in number of patients suffering from structural heart diseases
3.3.1.2. Technological advancements in heart valve replacement devices
3.3.1.3. Growth in demand for minimally invasive procedures
3.3.1.4. Increase in number of TAVR Centers

3.3.2. Restraints

3.3.2.1. High cost and risk associated with the treatment procedures
3.3.2.2. Stringent approval process for prosthetic heart valves

3.3.3. Opportunities

3.3.3.1. Lucrative opportunities in emerging economies
3.3.3.2. Use of transcatheter heart valves for new indications

3.3.4. Impact Analysis

3.4. GOVERNMENT REGULATIONS
3.5. REIMBURSEMENT SCENARIO
3.6. CLINICAL TRIALS

Chapter: 4 PROSTHETIC HEART VALVE MARKET, BY PRODUCT

4.1. OVERVIEW

4.1.1. Key market trends
4.1.2. Key growth factors and opportunities
4.1.3. Market size and forecast

4.2. MECHANICAL HEART VALVES

4.2.1. Key market trends
4.2.2. Market size and forecast

4.3. TISSUE HEART VALVES

4.3.1. Stented tissue heart valve
4.3.2. Stentless tissue heart valve
4.3.3. Key market trends
4.3.4. Market size and forecast

4.4. TRANSCATHETER HEART VALVES

4.4.1. Key market trends
4.4.2. Market size and forecast

Chapter: 5 PROSTHETIC HEART VALVE MARKET, BY REGION

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. NORTH AMERICA

5.2.1. Key market trends
5.2.2. Key growth factors and opportunities
5.2.3. Market size and forecast
5.2.4. U.S.
5.2.5. Canada
5.2.6. Mexico

5.3. EUROPE

5.3.1. Key market trends
5.3.2. Key growth factors and opportunities
5.3.3. Market size and forecast
5.3.4. Germany
5.3.5. France
5.3.6. UK
5.3.7. Italy
5.3.8. Spain
5.3.9. The Netherlands
5.3.10. Belgium
5.3.11. Switzerland
5.3.12. Russia
5.3.13. Denmark
5.3.14. Austria
5.3.15. Norway
5.3.16. Poland
5.3.17. Sweden
5.3.18. Rest of Europe

5.4. ASIA-PACIFIC

5.4.1. Key market trends
5.4.2. Key growth factors and opportunities
5.4.3. Market size and forecast
5.4.4. Japan
5.4.5. China
5.4.6. India
5.4.7. Australia
5.4.8. Malaysia
5.4.9. Republic of Korea
5.4.10. New Zealand
5.4.11. Singapore
5.4.12. Thailand
5.4.13. Vietnam
5.4.14. Taiwan
5.4.15. Indonesia
5.4.16. Rest of Asia-Pacific market size and forecast

5.5. LAMEA

5.5.1. Key market trends
5.5.2. Key growth factors and opportunities
5.5.3. Market size and forecast
5.5.4. Brazil
5.5.5. South Africa
5.5.6. Saudi Arabia
5.5.7. United Arab Emirates (UAE)
5.5.8. Libya
5.5.9. Algeria
5.5.10. Kenya
5.5.11. Kuwait
5.5.12. Jordan
5.5.13. Sudan
5.5.14. Morocco
5.5.15. Israel
5.5.16. Zimbabwe
5.5.17. Mauritius
5.5.18. Oman
5.5.19. Argentina
5.5.20. Iran
5.5.21. Iraq
5.5.22. Rest of LAMEA

Chapter: 6 COMPANY PROFILES

6.1 ABBOTT LABORATORIES

6.1.1 Company Overview
6.1.2 Company Snapshot
6.1.3 Operating Business Segments
6.1.4 Business Performance
6.1.5 Key Strategic Moves & Developments

6.2 BOSTON SCIENTIFIC CORPORATION

6.2.1 Company Overview
6.2.2 Company Snapshot
6.2.3 Operating Business Segments
6.2.4 Business Performance
6.2.5 Key Strategic Moves & Developments

6.3 CRYOLIFE, INC.

6.3.1 Company Overview
6.3.2 Company Snapshot
6.3.3 Operating Business Segments
6.3.4 Business Performance
6.3.5 Key Strategic Moves & Developments

6.4 DIRECT FLOW MEDICAL, INC.

6.4.1 Company Overview
6.4.2 Company Snapshot
6.4.3 Operating Business Segments
6.4.4 Key Strategic Moves & Developments

6.5 EDWARDS LIFESCIENCES CORPORATION

6.5.1 Company Overview
6.5.2 Company Snapshot
6.5.3 Operating Business Segments
6.5.4 Business Performance
6.5.5 Key Strategic Moves & Developments

6.6 JENAVALVE TECHNOLOGY, INC.

6.6.1 Company Overview
6.6.2 Company Snapshot
6.6.3 Operating Business Segments
6.6.4 Key Strategic Moves & Developments

6.7 LIVANOVA PLC

6.7.1 Company Overview
6.7.2 Company Snapshot
6.7.3 Operating Business Segments
6.7.4 Business Performance
6.7.5 Key Strategic Moves & Developments

6.8 MEDICAL TECHNOLOGY EST.

6.8.1 Company Overview
6.8.2 Company Snapshot
6.8.3 Operating Business Segments
6.8.4 Key Strategic Moves & Developments

6.9 MEDTRONIC PLC

6.9.1 Company Overview
6.9.2 Company Snapshot
6.9.3 Operating Business Segments
6.9.4 Business Performance
6.9.5 Key Strategic Moves & Developments

6.10 MICRO INTERVENTIONAL DEVICES, INC.

6.10.1 Company Overview
6.10.2 Company Snapshot
6.10.3 Operating Business Segments
6.10.4 Key Strategic Moves & Developments

LIST OF TABLES

TABLE 1. CPT CODE FOR HEART VALVE TECHNOLOGIES OF EDWARDS LIFESCIENCES
TABLE 2. CPT CODE RELATED TO TAVR OF EDWARD LIFESCIENCES
TABLE 3. GLOBAL PROSTHETIC HEART VALVE MARKET, BY TYPE ($MILLION), 2016-2023
TABLE 4. GLOBAL MECHANICAL HEART VALVE MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 5. GLOBAL MECHANICAL HEART VALVE MARKET, BY REGION, 2016-2023 (UNITS)
TABLE 6. GLOBAL TISSUE HEART VALVE MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 7. GLOBAL TISSUE HEART VALVE MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 8. GLOBAL TISSUE HEART VALVE MARKET, BY REGION, 2016-2023 (UNITS)
TABLE 9. GLOBAL TRANSCATHETER HEART VALVE HEART VALVE MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 10. GLOBAL TRANSCATHETER HEART VALVE HEART VALVE MARKET, BY REGION, 2016-2023 (UNITS)
TABLE 11. GLOBAL PROSTHETIC HEART VALVE HEART VALVE MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 12. GLOBAL PROSTHETIC HEART VALVE HEART VALVE MARKET, BY REGION, 2016-2023 (UNITS)
TABLE 13. NORTH AMERICA PROSTHETIC HEART VALVE MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 14. NORTH AMERICA PROSTHETIC HEART VALVE MARKET, BY COUNTRY, 2016-2023 (UNITS)
TABLE 15. NORTH AMERICA MECHANICAL HEART VALVE MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 16. NORTH AMERICA MECHANICAL HEART VALVE MARKET, BY COUNTRY, 2016-2023 (UNITS)
TABLE 17. NORTH AMERICA TISSUE HEART VALVE MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 18. NORTH AMERICA TISSUE HEART VALVE MARKET, BY COUNTRY, 2016-2023 (UNITS)
TABLE 19. NORTH AMERICA TRANSCATHETER HEART VALVE MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 20. NORTH AMERICA TRANSCATHETER HEART VALVE MARKET, BY COUNTRY, 2016-2023 (UNITS)
TABLE 21. EUROPE PROSTHETIC HEART VALVE MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 22. EUROPE PROSTHETIC HEART VALVE MARKET, BY COUNTRY, 2016-2023 (UNITS)
TABLE 23. EUROPE MECHANICAL HEART VALVE MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 24. EUROPE MECHANICAL HEART VALVE MARKET, BY COUNTRY, 2016-2023 (UNITS)
TABLE 25. EUROPE TISSUE HEART VALVE MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 26. EUROPE TISSUE HEART VALVE MARKET, BY COUNTRY, 2016-2023 (UNITS)
TABLE 27. EUROPE TRANSCATHETER HEART VALVE MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 28. EUROPE TRANSCATHETER HEART VALVE MARKET, BY COUNTRY, 2016-2023 (UNITS)
TABLE 29. ASIA-PACIFIC PROSTHETIC HEART VALVE MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 30. ASIA-PACIFIC PROSTHETIC HEART VALVE MARKET, BY COUNTRY, 2016-2023 (UNITS)
TABLE 31. ASIA-PACIFIC MECHANICAL HEART VALVE MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 32. ASIA-PACIFIC MECHANICAL HEART VALVE MARKET, BY COUNTRY, 2016-2023 (UNITS)
TABLE 33. ASIA-PACIFIC TISSUE HEART VALVE MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 34. ASIA-PACIFIC TISSUE HEART VALVE MARKET, BY COUNTRY, 2016-2023 (UNITS)
TABLE 35. ASIA-PACIFIC TRANSCATHETER HEART VALVE MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 36. ASIA-PACIFIC TRANSCATHETER HEART VALVE MARKET, BY COUNTRY, 2016-2023 (UNITS)
TABLE 37. LAMEA PROSTHETIC HEART VALVE MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 38. LAMEA PROSTHETIC HEART VALVE MARKET, BY COUNTRY, 2016-2023 (UNITS)
TABLE 39. LAMEA MECHANICAL HEART VALVE MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 40. LAMEA MECHANICAL HEART VALVE MARKET, BY COUNTRY, 2016-2023 (UNITS)
TABLE 41. LAMEA TISSUE HEART VALVE MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 42. LAMEA TISSUE HEART VALVE MARKET, BY COUNTRY, 2016-2023 (UNITS)
TABLE 43. LAMEA TRANSCATHETER HEART VALVE MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 44. LAMEA TRANSCATHETER HEART VALVE MARKET, BY COUNTRY, 2016-2023 (UNITS)
TABLE 45 ABBOTT: COMPANY SNAPSHOT
TABLE 46 ABBOTT: OPERATING SEGMENTS
TABLE 47 BOSTON SCIENTIFIC: COMPANY SNAPSHOT
TABLE 48 BOSTON SCIENTIFIC: OPERATING SEGMENTS
TABLE 49 CRYOLIFE: COMPANY SNAPSHOT
TABLE 50 CRYOLIFE: OPERATING SEGMENTS
TABLE 51 DIRECT FLOW MEDICAL: COMPANY SNAPSHOT
TABLE 52 EDWARDS LIFESCIENCES: COMPANY SNAPSHOT
TABLE 53 EDWARDS LIFESCIENCES: OPERATING SEGMENTS
TABLE 54 JENAVALVE TECHNOLOGY: COMPANY SNAPSHOT
TABLE 55 LIVANOVA: COMPANY SNAPSHOT
TABLE 56 LIVANOVA: OPERATING SEGMENTS
TABLE 57 MEDICAL TECHNOLOGY EST: COMPANY SNAPSHOT
TABLE 58 MEDTRONIC: COMPANY SNAPSHOT
TABLE 59 MEDTRONIC: OPERATING SEGMENTS
TABLE 60 MICRO INTERVENTIONAL DEVICES: COMPANY SNAPSHOT

LIST OF FIGURES

FIGURE 1. PROSTHETIC HEART VALVE MARKET SEGMENTATION
FIGURE 2. TOP INVESTMENT POCKETS
FIGURE 3. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION (%)
FIGURE 4. TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 5. TOP COMPANIES AND THEIR STRATEGIES
FIGURE 6. DETAILED STRUCTURE OF COMPANIES AND TYPE OF STRATEGIES
FIGURE 7. DETAILED STRUCTURE OF COMPANIES AND NATURE OF STRATEGIES
FIGURE 8. MARKET SHARE ANALYSIS, 2016
FIGURE 9. CLINICAL TRIALS FOR PROSTHETIC HEART VALVE MARKET, BY TYPE (%)
FIGURE 10. CLINICAL TRIALS FOR PROSTHETIC HEART VALVE MARKET, BY REGION (%)
FIGURE 11. CLINICIAL TRIALS FOR MECHANICAL HEART VALVES (%)
FIGURE 12. CLINICIAL TRIALS FOR TISSUE HEART VALVES (%)
FIGURE 13. CLINICIAL TRIALS FOR TRANSCATHETER HEART VALVES (%)
FIGURE 14. GLOBAL PROSTHETIC HEART VALVE MARKET, BY TYPE, 2016-2023 ($MILLION)
FIGURE 15. GLOBAL MECHANICAL HEART VALVE MARKET, BY REGION, 2016-2023 ($MILLION)
FIGURE 16. GLOBAL MECHANICAL HEART VALVE MARKET, BY REGION, 2016-2023 (UNITS)
FIGURE 17. GLOBAL TISSUE HEART VALVE MARKET, BY TYPE, 2016-2023 ($MILLION)
FIGURE 18. GLOBAL TISSUE HEART VALVE MARKET, BY REGION, 2016-2023 ($MILLION)
FIGURE 19. GLOBAL TISSUE HEART VALVE MARKET, BY REGION, 2016-2023 (UNITS)
FIGURE 20. GLOBAL TRANSCATHETER HEART VALVE HEART VALVE MARKET, BY REGION, 2016-2023 ($MILLION)
FIGURE 21. GLOBAL TRANSCATHETER HEART VALVE HEART VALVE MARKET, BY REGION, 2016-2023 (UNITS)
FIGURE 22. TOTAL NUMBER OF TAVR CANDIDATES WORLDWIDE
FIGURE 23. GLOBAL PROSTHETIC HEART VALVE HEART VALVE MARKET, BY REGION, 2016-2023 ($MILLION)
FIGURE 24. GLOBAL PROSTHETIC HEART VALVE HEART VALVE MARKET, BY REGION, 2016-2023 (UNITS)
FIGURE 25. NORTH AMERICA PROSTHETIC HEART VALVE MARKET, BY COUNTRY, 2016-2023 ($MILLION)
FIGURE 26. NORTH AMERICA PROSTHETIC HEART VALVE MARKET, BY COUNTRY, 2016-2023 (UNITS)
FIGURE 27. NORTH AMERICA MECHANICAL HEART VALVE MARKET, BY COUNTRY, 2016-2023 ($MILLION)
FIGURE 28. NORTH AMERICA MECHANICAL HEART VALVE MARKET, BY COUNTRY, 2016-2023 (UNITS)
FIGURE 29. NORTH AMERICA TISSUE HEART VALVE MARKET, BY COUNTRY, 2016-2023 ($MILLION)
FIGURE 30. NORTH AMERICA TISSUE HEART VALVE MARKET, BY COUNTRY, 2016-2023 (UNITS)
FIGURE 31. NORTH AMERICA TRANSCATHETER HEART VALVE MARKET, BY COUNTRY, 2016-2023 ($MILLION)
FIGURE 32. NORTH AMERICA TRANSCATHETER HEART VALVE MARKET, BY COUNTRY, 2016-2023 (UNITS)
FIGURE 33. U.S. PROSTHETIC HEART VALVE MARKET, 2016-2023 ($MILLION)
FIGURE 34. U.S. PROSTHETIC HEART VALVE MARKET, 2016-2023 (UNITS)
FIGURE 35. CANADA PROSTHETIC HEART VALVE MARKET, 2016-2023 ($MILLION)
FIGURE 36. CANADA PROSTHETIC HEART VALVE MARKET, 2016-2023 (UNITS)
FIGURE 37. MEXICO PROSTHETIC HEART VALVE MARKET, 2016-2023 ($MILLION)
FIGURE 38. MEXICO PROSTHETIC HEART VALVE MARKET, 2016-2023 (UNITS)
FIGURE 39. EUROPE PROSTHETIC HEART VALVE MARKET, BY COUNTRY, 2016-2023 ($MILLION)
FIGURE 40. EUROPE PROSTHETIC HEART VALVE MARKET, BY COUNTRY, 2016-2023 (UNITS)
FIGURE 41. EUROPE MECHANICAL HEART VALVE MARKET, BY COUNTRY, 2016-2023 ($MILLION)
FIGURE 42. EUROPE MECHANICAL HEART VALVE MARKET, BY COUNTRY, 2016-2023 (UNITS)
FIGURE 43. EUROPE TISSUE HEART VALVE MARKET, BY COUNTRY, 2016-2023 ($MILLION)
FIGURE 44. EUROPE TISSUE HEART VALVE MARKET, BY COUNTRY, 2016-2023 (UNITS)
FIGURE 45. EUROPE TRANSCATHETER HEART VALVE MARKET, BY COUNTRY, 2016-2023 ($MILLION)
FIGURE 46. EUROPE TRANSCATHETER HEART VALVE MARKET, BY COUNTRY, 2016-2023 (UNITS)
FIGURE 47. GERMANY PROSTHETIC HEART VALVE MARKET, 2016-2023 ($MILLION)
FIGURE 48. GERMANY PROSTHETIC HEART VALVE MARKET, 2016-2023 (UNITS)
FIGURE 49. FRANCE PROSTHETIC HEART VALVE MARKET, 2016-2023 ($MILLION)
FIGURE 50. FRANCE PROSTHETIC HEART VALVE MARKET, 2016-2023 (UNITS)
FIGURE 51. UK PROSTHETIC HEART VALVE MARKET, 2016-2023 ($MILLION)
FIGURE 52. UK PROSTHETIC HEART VALVE MARKET, 2016-2023 (UNITS)
FIGURE 53. ITALY PROSTHETIC HEART VALVE MARKET, 2016-2023 ($MILLION)
FIGURE 54. ITALY PROSTHETIC HEART VALVE MARKET, 2016-2023 (UNITS)
FIGURE 55. SPAIN PROSTHETIC HEART VALVE MARKET, 2016-2023 ($MILLION)
FIGURE 56. SPAIN PROSTHETIC HEART VALVE MARKET, 2016-2023 (UNITS)
FIGURE 57. THE NETHERLANDS PROSTHETIC HEART VALVE MARKET, 2016-2023 ($MILLION)
FIGURE 58. THE NETHERLANDS PROSTHETIC HEART VALVE MARKET, 2016-2023 (UNITS)
FIGURE 59. BELGIUM PROSTHETIC HEART VALVE MARKET, 2016-2023 ($MILLION)
FIGURE 60. BELGIUM PROSTHETIC HEART VALVE MARKET, 2016-2023 (UNITS)
FIGURE 61. SWITZERLAND PROSTHETIC HEART VALVE MARKET, 2016-2023 ($MILLION)
FIGURE 62. SWITZERLAND PROSTHETIC HEART VALVE MARKET, 2016-2023 (UNITS)
FIGURE 63. RUSSIA PROSTHETIC HEART VALVE MARKET, 2016-2023 ($MILLION)
FIGURE 64. RUSSIA PROSTHETIC HEART VALVE MARKET, 2016-2023 (UNITS)
FIGURE 65. DENMARK PROSTHETIC HEART VALVE MARKET, 2016-2023 ($MILLION)
FIGURE 66. DENMARK PROSTHETIC HEART VALVE MARKET, 2016-2023 (UNITS)
FIGURE 67. AUSTRIA PROSTHETIC HEART VALVE MARKET, 2016-2023 ($MILLION)
FIGURE 68. AUSTRIA PROSTHETIC HEART VALVE MARKET, 2016-2023 (UNITS)
FIGURE 69. NORWAY PROSTHETIC HEART VALVE MARKET, 2016-2023 ($MILLION)
FIGURE 70. NORWAY PROSTHETIC HEART VALVE MARKET, 2016-2023 (UNITS)
FIGURE 71. POLAND PROSTHETIC HEART VALVE MARKET, 2016-2023 ($MILLION)
FIGURE 72. POLAND PROSTHETIC HEART VALVE MARKET, 2016-2023 (UNITS)
FIGURE 73. SWEDEN PROSTHETIC HEART VALVE MARKET, 2016-2023 ($MILLION)
FIGURE 74. SWEDEN PROSTHETIC HEART VALVE MARKET, 2016-2023 (UNITS)
FIGURE 75. REST OF EUROPE PROSTHETIC HEART VALVE MARKET, 2016-2023 ($MILLION)
FIGURE 76. REST OF EUROPE PROSTHETIC HEART VALVE MARKET, 2016-2023 (UNITS)
FIGURE 77. ASIA-PACIFIC PROSTHETIC HEART VALVE MARKET, BY COUNTRY, 2016-2023 ($MILLION)
FIGURE 78. ASIA-PACIFIC PROSTHETIC HEART VALVE MARKET, BY COUNTRY, 2016-2023 (UNITS)
FIGURE 79. ASIA-PACIFIC MECHANICAL HEART VALVE MARKET, BY COUNTRY, 2016-2023 ($MILLION)
FIGURE 80. ASIA-PACIFIC MECHANICAL HEART VALVE MARKET, BY COUNTRY, 2016-2023 (UNITS)
FIGURE 81. ASIA-PACIFIC TISSUE HEART VALVE MARKET, BY COUNTRY, 2016-2023 ($MILLION)
FIGURE 82. ASIA-PACIFIC TISSUE HEART VALVE MARKET, BY COUNTRY, 2016-2023 (UNITS)
FIGURE 83. ASIA-PACIFIC TRANSCATHETER HEART VALVE MARKET, BY COUNTRY, 2016-2023 ($MILLION)
FIGURE 84. ASIA-PACIFIC TRANSCATHETER HEART VALVE MARKET, BY COUNTRY, 2016-2023 (UNITS)
FIGURE 85. JAPAN PROSTHETIC HEART VALVE MARKET, 2016-2023 ($MILLION)
FIGURE 86. JAPAN PROSTHETIC HEART VALVE MARKET, 2016-2023 (UNITS)
FIGURE 87. CHINA PROSTHETIC HEART VALVE MARKET, 2016-2023 ($MILLION)
FIGURE 88. CHINA PROSTHETIC HEART VALVE MARKET, 2016-2023 (UNITS)
FIGURE 89. INDIA PROSTHETIC HEART VALVE MARKET, 2016-2023 ($MILLION)
FIGURE 90. INDIA PROSTHETIC HEART VALVE MARKET, 2016-2023 (UNITS)
FIGURE 91. AUSTRALIA PROSTHETIC HEART VALVE MARKET, 2016-2023 ($MILLION)
FIGURE 92. AUSTRALIA PROSTHETIC HEART VALVE MARKET, 2016-2023 (UNITS)
FIGURE 93. MALAYSIA PROSTHETIC HEART VALVE MARKET, 2016-2023 ($MILLION)
FIGURE 94. MALAYSIA PROSTHETIC HEART VALVE MARKET, 2016-2023 (UNITS)
FIGURE 95. REPUBLIC OF KOREA PROSTHETIC HEART VALVE MARKET, 2016-2023 ($MILLION)
FIGURE 96. REPUBLIC OF KOREA PROSTHETIC HEART VALVE MARKET, 2016-2023 (UNITS)
FIGURE 97. NEW ZEALAND PROSTHETIC HEART VALVE MARKET, 2016-2023 ($MILLION)
FIGURE 98. NEW ZEALAND PROSTHETIC HEART VALVE MARKET, 2016-2023 (UNITS)
FIGURE 99. SINGAPORE PROSTHETIC HEART VALVE MARKET, 2016-2023 ($MILLION)
FIGURE 100. SINGAPORE PROSTHETIC HEART VALVE MARKET, 2016-2023 (UNITS)
FIGURE 101. THAILAND PROSTHETIC HEART VALVE MARKET, 2016-2023 ($MILLION)
FIGURE 102. THAILAND PROSTHETIC HEART VALVE MARKET, 2016-2023 (UNITS)
FIGURE 103. VIETNAM PROSTHETIC HEART VALVE MARKET, 2016-2023 ($MILLION)
FIGURE 104. VIETNAM PROSTHETIC HEART VALVE MARKET, 2016-2023 (UNITS)
FIGURE 105. TAIWAN PROSTHETIC HEART VALVE MARKET, 2016-2023 ($MILLION)
FIGURE 106. TAIWAN PROSTHETIC HEART VALVE MARKET, 2016-2023 (UNITS)
FIGURE 107. BELGIUM PROSTHETIC HEART VALVE MARKET, 2016-2023 ($MILLION)
FIGURE 108. BELGIUM PROSTHETIC HEART VALVE MARKET, 2016-2023 (UNITS)
FIGURE 109. REST OF ASIA-PACIFIC PROSTHETIC HEART VALVE MARKET, 2016-2023 ($MILLION)
FIGURE 110. REST OF ASIA-PACIFIC PROSTHETIC HEART VALVE MARKET, 2016-2023 (UNITS)
FIGURE 111. LAMEA PROSTHETIC HEART VALVE MARKET, BY COUNTRY, 2016-2023 ($MILLION)
FIGURE 112. LAMEA PROSTHETIC HEART VALVE MARKET, BY COUNTRY, 2016-2023 (UNITS)
FIGURE 113. LAMEA MECHANICAL HEART VALVE MARKET, BY COUNTRY, 2016-2023 ($MILLION)
FIGURE 114. LAMEA MECHANICAL HEART VALVE MARKET, BY COUNTRY, 2016-2023 (UNITS)
FIGURE 115. LAMEA TISSUE HEART VALVE MARKET, BY COUNTRY, 2016-2023 ($MILLION)
FIGURE 116. LAMEA TISSUE HEART VALVE MARKET, BY COUNTRY, 2016-2023 (UNITS)
FIGURE 117. LAMEA TRANSCATHETER HEART VALVE MARKET, BY COUNTRY, 2016-2023 ($MILLION)
FIGURE 118. LAMEA TRANSCATHETER HEART VALVE MARKET, BY COUNTRY, 2016-2023 (UNITS)
FIGURE 119. BRAZIL PROSTHETIC HEART VALVE MARKET, 2016-2023 ($MILLION)
FIGURE 120. BRAZIL PROSTHETIC HEART VALVE MARKET, 2016-2023 (UNITS)
FIGURE 121. SOUTH AFRICA PROSTHETIC HEART VALVE MARKET, 2016-2023 ($MILLION)
FIGURE 122. SOUTH AFRICA PROSTHETIC HEART VALVE MARKET, 2016-2023 (UNITS)
FIGURE 123. SAUDI ARABIA PROSTHETIC HEART VALVE MARKET, 2016-2023 ($MILLION)
FIGURE 124. SAUDI ARABIA PROSTHETIC HEART VALVE MARKET, 2016-2023 (UNITS)
FIGURE 125. UAE PROSTHETIC HEART VALVE MARKET, 2016-2023 ($MILLION)
FIGURE 126. UAE PROSTHETIC HEART VALVE MARKET, 2016-2023 (UNITS)
FIGURE 127. LIBYA PROSTHETIC HEART VALVE MARKET, 2016-2023 ($MILLION)
FIGURE 128. LIBYA PROSTHETIC HEART VALVE MARKET, 2016-2023 (UNITS)
FIGURE 129. ALGERIA PROSTHETIC HEART VALVE MARKET, 2016-2023 ($MILLION)
FIGURE 130. ALGERIA PROSTHETIC HEART VALVE MARKET, 2016-2023 (UNITS)
FIGURE 131. KENYA PROSTHETIC HEART VALVE MARKET, 2016-2023 ($MILLION)
FIGURE 132. KENYA PROSTHETIC HEART VALVE MARKET, 2016-2023 (UNITS)
FIGURE 133. KUWAIT PROSTHETIC HEART VALVE MARKET, 2016-2023 ($MILLION)
FIGURE 134. KUWAIT PROSTHETIC HEART VALVE MARKET, 2016-2023 (UNITS)
FIGURE 135. JORDAN PROSTHETIC HEART VALVE MARKET, 2016-2023 ($MILLION)
FIGURE 136. JORDAN PROSTHETIC HEART VALVE MARKET, 2016-2023 (UNITS)
FIGURE 137. SUDAN PROSTHETIC HEART VALVE MARKET, 2016-2023 ($MILLION)
FIGURE 138. SUDAN PROSTHETIC HEART VALVE MARKET, 2016-2023 (UNITS)
FIGURE 139. MOROCCO PROSTHETIC HEART VALVE MARKET, 2016-2023 ($MILLION)
FIGURE 140. MOROCCO PROSTHETIC HEART VALVE MARKET, 2016-2023 (UNITS)
FIGURE 141. ISRAEL PROSTHETIC HEART VALVE MARKET, 2016-2023 ($MILLION)
FIGURE 142. ISRAEL PROSTHETIC HEART VALVE MARKET, 2016-2023 (UNITS)
FIGURE 143. ZIMBABWE PROSTHETIC HEART VALVE MARKET, 2016-2023 ($MILLION)
FIGURE 144. ZIMBABWE PROSTHETIC HEART VALVE MARKET, 2016-2023 (UNITS)
FIGURE 145. MAURITIUS PROSTHETIC HEART VALVE MARKET, 2016-2023 ($MILLION)
FIGURE 146. MAURITIUS PROSTHETIC HEART VALVE MARKET, 2016-2023 (UNITS)
FIGURE 147. OMAN PROSTHETIC HEART VALVE MARKET, 2016-2023 ($MILLION)
FIGURE 148. OMAN PROSTHETIC HEART VALVE MARKET, 2016-2023 (UNITS)
FIGURE 149. ARGENTINA PROSTHETIC HEART VALVE MARKET, 2016-2023 ($MILLION)
FIGURE 150. ARGENTINA PROSTHETIC HEART VALVE MARKET, 2016-2023 (UNITS)
FIGURE 151. IRAN PROSTHETIC HEART VALVE MARKET, 2016-2023 ($MILLION)
FIGURE 152. IRAN PROSTHETIC HEART VALVE MARKET, 2016-2023 (UNITS)
FIGURE 153. IRAQ PROSTHETIC HEART VALVE MARKET, 2016-2023 ($MILLION)
FIGURE 154. IRAQ PROSTHETIC HEART VALVE MARKET, 2016-2023 (UNITS)
FIGURE 155. REST OF LAMEA PROSTHETIC HEART VALVE MARKET, 2016-2023 ($MILLION)
FIGURE 156. REST OF LAMEA PROSTHETIC HEART VALVE MARKET, 2016-2023 (UNITS)

 

The adoption of prosthetic heart valves is expected to increase in future, owing to the high prevalence rate of cardiovascular disorders and rise in geriatric population. The prosthetic heart valves market has piqued the interest of healthcare providers, owing to the benefits associated with these devices to treat valvular heart disorders. There have been significant technological advancements in the prosthetic heart valves to facilitate the advanced treatments for disease management. Asia-Pacific and LAMEA are expected to offer lucrative opportunities for the market players during the forecast period.

The market is driven by the growth in incidence of cardiac disorders, increase in geriatric population, rise in patient awareness, demand for minimally invasive cardiovascular surgeries, technological advancements in heart repair & replacement devices, and surge in transcatheter heart valve surgery centers. However, enormous expenditure and risks associated with prosthetic valve implantation procedure and robust guidelines for approval of prosthetic valves restrict the market growth. Conversely, use of transcatheter heart valves for new indications and growth opportunities in emerging countries of Asia-Pacific and LAMEA are expected to provide several opportunities for market growth during the forecast period. Moreover, North America is expected to dominate the global prosthetic heart valves market during the forecast period, followed by Europe.

 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 

Request Sample

Request Customization

Request sample

OR

Purchase Full Report of
Prosthetic Heart Valve Market- Global Opportunity Analysis and Industry Forecast, 2017-2023

  • Online Only
  • $4176 $3759
  • Online cloud Access only
  • Restricted Print, copy, paste,download
  • Read Only
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Data Pack
  • $4640 $4176
  • Restricted to one authorized users
  • One print only
  • Available in Excel
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $5540 $4709
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $6654 $5324
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprise
    License/PDF

  • $9280 $6960
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Access reports on all emerging
market of Life Sciences on Knowledge Tree Platform
Free Demo